Business ❯ Finance

Corporate Governance

Board of Directors Regulatory Compliance Executive Compensation Shareholder Rights Leadership Shareholder Relations Executive Leadership Mergers and Acquisitions Leadership Changes Investor Relations

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

The decision underscores the FDA’s insistence on well‑controlled efficacy data over single‑arm results.

Nakamoto Seeks 1-for-20 to 1-for-50 Reverse Split to Preserve Nasdaq Listing

Driven Brands Investors Face May 8 Lead‑Plaintiff Deadline as Firms Press SDNY Securities Case

ISS and Glass Lewis Back WBD Sale, Urge No on Zaslav’s $887 Million Payout

Bitmine Uplists to NYSE and Expands Share Buyback to $4 Billion

FICO Plunges 13% as Senate Probe and AI Worries Batter Credit-Score Leader

Apple Seeks Samsung Records in South Korea for DOJ Antitrust Case

Constellation Brands Beats Q4, Withdraws 2028 Outlook, Issues Cautious FY2027 Guidance

Circle Drops After Sell Call on Margin Strain From Partner-Led USDC Growth

Bidders Weigh Purchases of Gemini’s Shuttered U.K. and EU Units for Licenses

Sumitomo, SMBC, Apollo and Brookfield Close Air Lease Buyout, Rebrand as Sumisho Air Lease

Ares to Take Whitestone REIT Private in $1.7 Billion All-Cash Deal at $19 a Share

Workday Slides 6% After Founder Sale and Anthropic Agent Launch

New Era Energy & Digital Prices $100 Million Stock Sale at $3.35

Dimon Warns New York Taxes Threaten Competitiveness

Wingstop Draws Fresh Upgrades After 30% Year-to-Date Slide

Oracle Names Hilary Maxson CFO as AI Data‑Center Spending Accelerates

Cramer Praise Lifts Nebius Shares

Trade Desk Shares Rebound After-Hours as Three Senior Leaders Exit

Avis Budget Soars to Four-Year High on Options-Fueled Squeeze